In search of signaling pathways critical for ovarian graft reception: Akt1 is essential for long-term survival of ovarian grafts  by Cohen, Yoni et al.
ORIGINAL ARTICLES: REPRODUCTIVE SCIENCEIn search of signaling pathways
critical for ovarian graft reception:
Akt1 is essential for long-term
survival of ovarian grafts
Yoni Cohen, M.D.,a Hagit Dafni, Ph.D.,b Reut Avni, M.S.C.,a Tal Raz, D.V.M., Ph.D., D.A.C.T.,a,c
Inbal Biton, Ph.D.,b Brian Hemmings, Ph.D.,d and Michal Neeman, Ph.D.a
a Department of Biological Regulation and b Department of Veterinary Resources, Weizmann Institute of Science, Rehovot,
Israel; c Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel; and d Friedrich Miescher
Institute for Biomedical Research, Basel, SwitzerlandObjective: To explore the role of Akt1, a principle modulator of angiogenesis, in ovarian graft reception and to investigate whether
Akt1 deﬁciency can alter ovarian graft reception.
Design: Experimental mouse model.
Setting: Research institute.
Animal(s): Donors: Akt1 knockout (Akt1/) and wild types (Akt1þ/þ) mice. Recipients: CD-1 nude immune deﬁcient female mice.
Intervention(s): Ovaries from Akt1/ and Akt1þ/þ mice transplanted in the biceps femoris muscle of immunocompromised CD-1
mice, and ovarian graft viability, perfusion, and revascularization explored in vivo by magnetic resonance imaging (MRI).
Main Outcome Measure(s): Vascular density and permeability of newly formed graft blood vessels quantiﬁed by dynamic contrast–
enhanced MRI 7, 14, 30, and 60 days after grafting as indicators for angiogenesis and reestablishment of blood perfusion.
Result(s): The Akt1/ ovarian grafts showed a gradual decrease in angiogenic response with time after transplantation, ultimately
leading to complete or near-complete graft destruction coinciding with massive follicular loss. Sixty days after transplantation, the
mean blood volume fraction (fBV) and vessel permeability (PS) were statistically signiﬁcantly lower in Akt1/ transplants
compared with Akt1þ/þ.Use your smartphoneConclusion(s): Akt1 is essential for ovarian graft reception. However, surprisingly the impact
of Akt1 deﬁciency was most profound not in the early stages of angiogenesis but rather in long-
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access under CC BY-NC-ND license. Ovarian tissue cryopreservation and
transplantation are one of a few
available treatments for fertility
preservation in women diagnosed
with cancer. Worldwide, approxi-
mately 24 babies have been born so
far after successful ovarian graft
transplantation (4).
Laparoscopic retrieval of ovarian
cortex fragments followed by their
cryopreservation provides a rapid
approach for preservation of fertility,
with the advantage that it is also appli-
cable for young girls and adolescents
and does not require a partner or donor
sperm. After thawing, cortical ovarian
fragments are transplanted eitherVOL. 101 NO. 2 / FEBRUARY 2014
Fertility and Sterility®orthotopically or heterotopically. This avascular tissue
transplantation procedure without surgical anastomosis re-
sults in a low success rate mainly due to posttransplantation
graft hypoxia. Hypoxic damage causes reduced graft size
with ﬁbrotic changes and critical loss (up to 90%) of primor-
dial follicles in the ﬁrst few days after transplantation (5).
We have previously reported that angiogenesis starts on
the third day after transplantation whereas complete blood
perfusion is achieved only on day 6 (6). Progressive revascu-
larization coupled with an increase in the partial pressure of
oxygen in ovarian grafts was documented from days 5 to 10
(7, 8). Therefore, reducing graft hypoxia and subsequent
damage to the ovarian graft is the main goal of research in
this ﬁeld. So far methods for improving graft
revascularization and minimizing the hypoxic damage that
were described include induction of angiogenesis by
transplantation into granulation tissue (9, 10) and
reducing hypoxic damage by antioxidant treatments such
as vitamin E and melatonin, vascular endothelial growth
factor A (VEGF-A), and hyaluronan (11–14).
The phosphatidylinositol-3 kinase (PI3K)-Akt signaling
pathway has multiple roles in the cell. Data generated from
in vivo and in vitro experiments suggest that Akt1, which is
the predominant isoform of Akt in endothelial cells, acts as
a principal mediator of angiogenic response, vascular perme-
ability, and vascular maturation (15). Under hypoxic condi-
tions, Akt1 mediates expression of VEGF (16), and Akt1
activity is necessary for VEGF-mediated endothelial cells'
proliferation andmigration (17). Akt1 is activated in endothe-
lial cells in response to other key proangiogenic signaling fac-
tors such as angiopoietin and ﬁbroblast growth factor 2 (18,
19). However, although the role of Akt1 has been
investigated thoroughly, there are still questions about its
angiogenic effect in different animal models. Chen et al.
(20) found increased vascular density in tumors grafted into
Akt1/ mice, suggesting that lack of Akt1 causes
enhanced angiogenesis in the short-term and immature blood
vessels later. In contrast with that study, other studies per-
formed using ischemia models revealed that Akt1-deﬁcient
mice exhibit reduced angiogenesis, endothelial progenitor
cell mobilization, vessel permeability, and nitric oxide release
in response to VEGF injection (18).
In view of the principal and complex role of Akt1 in
angiogenesis and vascular function and our continuous
search for an efﬁcient method to induce active angiogenesis
at the site of ovarian graft implantation, we designed this
study to delineate the role of graft expression of Akt1 in
ovarian graft reception. We speciﬁcally investigated whether
Akt1 loss of function can improve or compromise ovarian
graft reception. We used in vivo dynamic contrast enhanced
(DCE) magnetic resonance imaging (MRI) to observe ovarian
grafts that had been retrieved from Akt1-deﬁcient mice and
transplanted into wild-type immunodeﬁcient mice. The MRI
data enable both temporal and spatial follow-up observation
of ovarian grafts, demonstrating the key role of ovarian graft
Akt1 in their reception. These results may serve as the ﬁrst
step toward understanding the molecular signaling pathways
that should be modulated to affect ovarian graft
revascularization.VOL. 101 NO. 2 / FEBRUARY 2014MATERIALS AND METHODS
All animal experiments were approved by the Weizmann
institutional animal care and use committee.Ovarian Graft Harvesting
Ovaries were collected from donor Akt1 wild-type (Akt1þ/þ)
mice and mice with loss of Akt1 expression (Akt1/) at the
beginning of their sexual maturity, 5–6 weeks of age (21).
Mice were sacriﬁced using CO2 inhalation, and the ovaries
were collected and cleaned of fat and other tissues in a
phosphate-buffered saline (PBS) solution maintained at
37C. Because this model focuses on angiogenesis and
vascular remodeling during the critical ischemic interval after
transplantation, we used a fresh ovarian graft that was trans-
planted within 15 minutes from retrieval to minimize
ischemic damage to the tissue.Ovarian Graft Transplantation
Ovarian grafts were transplanted in 6- to 9-week-old CD-1
nude female mice (n ¼ 14). Before the ovarian tissue trans-
plantation, the recipient mice [1] underwent ovariectomy 2
to 3 weeks before transplantation and [2] had a 5-mm wound
made in the biceps femoris muscle of the thigh 5 days before
transplantation to form a granulation tissue at the site of
implantation.
For the ovarian transplantation, recipient CD-1 nude
mice were anesthetized with 100 mg/kg ketamine (Kepro)
and 20 mg/kg xylazine (Eurovet), injected intraperitoneally.
The transplantation site in the biceps femoris muscle was
cleaned of blood clots and debris and rinsed with PBS. The
ovary was transplanted intramuscularly at the site of granu-
lation tissue created by the incision 5 days earlier. The edges
of the muscle were closed over the graft with 7/0 Prolene
(Ethicon), taking care not to traverse and damage the ovarian
tissue. The skin incision was closed with 5/0 (Mersilk; Ethi-
con) silk sutures and covered with Super Glue Gel (ethyl
cyanoacrylate; Loctite) to seal the wound.In Vivo Dynamic Contrast-Enhanced MRI of
Ovarian Grafts
The MRI experiments were performed at 9.4 T on a horizontal
Biospec spectrometer (Bruker) using a linear coil for excita-
tion and a 2-cm surface coil for detection (Bruker). The ani-
mals were anesthetized with isoﬂurane (3% for induction,
1% to 2% for maintenance [Abbott Laboratories] in 1 liter/
min oxygen delivered through a muzzle mask) and kept under
respiratory monitoring. Body temperature was maintained
using a heated bed.
The recipient mice were serially scanned 7, 14, 30, and 60
days after transplantation. Three dimensional gradient echo
(3D-GE) images of the graft were acquired before and sequen-
tially for 40 minutes after intravenous administration of
contrast agent. A series of variable ﬂip angle precontrast
T1-weighted 3D-GE images were acquired to determine the
precontrast R1 (repetition time [TR]: 10 msec; echo time
[TE]: 2.8 msec; ﬂip angles: 5, 15, 30, 50, 70; two537
ORIGINAL ARTICLE: REPRODUCTIVE SCIENCEaverages; matrix: 256  256  64; ﬁeld of view [FOV]: 35 
35  35 mm3). The postcontrast images were obtained with a
single ﬂip angle (15).
The macromolecular contrast agent Biotin-BSA-GdDTPA
(80 kDa) [(diethylenetriaminepentaacetic acid)-bis(stearyla-
mide) (gadolinium salt)] was synthesized as previously
described by Dafni et al. (22). During MRI experiments,
Biotin-BSA-GdDTPA (10 mg/mouse in 0.2 mL of PBS) was in-
jected intravenously through a preplaced silicone catheter in-
serted into the tail vein.Analysis of Dynamic MR Data
Pixel by pixel analysis was performed using Matlab software
(Math Works Inc.) to generate R1 maps and consequently
concentration maps of biotin-BSA-GdDTPA (23) in the grafts
and surrounding tissues for selected slices. The dynamics of
contrast agent accumulation in the graft was used for analysis
of vessel density (blood volume fraction) and vessel perme-
ability. Vascular properties were derived from data analysis
of parameters extracted from selected regions of interest
(ROI):
1. Blood volume fraction (fBV): the ratio between the extrap-
olated concentration of contrast agent at the time of
administration and the initial concentration in the blood
(at time 0, after the ﬁrst postinjection scan, approximately
5 minutes after contrast agent injection).
2. Permeability surface area product (PS, min1): the initial
rate of contrast accumulation normalized to initial blood
concentration, reﬂecting the leakage of the macromolec-
ular contrast agent out of the vascular compartment and
its accumulation in the interstitial space.
The mean fBV and PS values were calculated for each
graft from parameters maps by manually drawing regions
of interest (ROIs) that encompassed the graft in all relevant
slices of the 3D data set.Histologic Assessment of Microvascular Density
and Permeability
The ovarian graft and surrounding muscle were retrieved for
histologic study at the end of the last serial MRI scan (day 60),
approximately 40 minutes after injection of biotin-BSA-
GdDTPA. Before tissue retrieval, the additional contrast mate-
rial, bovine serum albumin (BSA) labeled with a rhodamine
derivative ROX (Invitrogen) (24), was injected through the
tail vein catheter (2.5 mg/mouse in 0.2 mL of PBS). The ani-
mals were sacriﬁced 2 minutes after the administration of
BSA-ROX such that it remained inside the lumen of blood
vessels with minimal leakage.
To preserve the biotin and ﬂuorescent tags, the retrieved
tissue was placed in Carnoy ﬁxative solution (6:3:1 ethanol/
chloroform/acetic acid) for 24 hours at 4C and then trans-
ferred to 70% ethanol. The ﬁxed samples were embedded in
parafﬁn blocks and sectioned serially at 4-mm thickness.
Morphometric data were obtained by multilevel sampling of
the graft at 120-mm intervals. The density of functional blood
vessels was assessed directly from the ﬂuorescent signal of the538intravascular BSA-ROX. Permeability was assessed from the
distribution of the extravasated biotin-BSA-GdDTPA, visual-
ized by staining the histologic sections with avidin-CY2 con-
jugate (Jackson ImmunoResearch). Images were obtained
with a Zeiss Axio observer microscope equipped with a ﬂuo-
rescence illuminator and an Olympus DP72 camera and were
analyzed using ImageJ software (U.S. National Institutes of
Health; http://rsb.info.nih.gov/ij/).Immunohistochemical Staining of Mature Blood
Vessels
Histologic sections were stained with monoclonal anti-a-
smooth muscle actin (a-SMA; Novus Biologicals), which is
present in the perivascular pericytes or vascular smooth mus-
cle cells. After deparafﬁnization, the slides were incubated
with a-SMA antibodies (1:500) overnight at 4C and were de-
tected using a second antibody with alkaline phosphatase
(Jackson ImmunoResearch) and visualized with Fast Red
(Sigma-Aldrich). The slides were counterstained with Mayer's
hematoxylin solution, and were examined with a Nikon
Eclipse E800 microscope.Morphologic Assessment of the Native Akt1L/L
Ovary
Before harvesting and implanting Akt1 transgenic grafts, we
assessed ovarian morphology in native ovaries. Ovaries from
adult cycling (13- to 24-week-old) Akt1/ and Akt1þ/þmice
were collected and ﬁxed in 4% formaldehyde for 24 hours at
4C and then transferred to 70% ethanol. The ﬁxed ovaries
were embedded in parafﬁn blocks, and a representative four
to ﬁve sections were taken from the middle of each ovary.
This gross morphometric analysis was used to search for ma-
jor semiquantitative differences between the native ovary and
ovarian grafts.Statistical Analysis
Statistical analyses were performed with analytic computer-
ized software (Statistix 8 Student Edition; Analytical Soft-
ware). The general effects of the animal, the genotype, the
day, and the day by genotype interaction, on PS and fBV
data were analyzed in a repeated measures analysis of vari-
ance (ANOVA), followed by a Tukey honest signiﬁcant differ-
ence all-pairwise comparisons test. When applicable, on each
scanning day (e.g., days 7, 14, 30, and 60), PS and fBV data
were compared between groups using Kruskal-Wallis
nonparametric one-way ANOVA. P< .05 was considered sta-
tistically signiﬁcant. Results are presented as mean  stan-
dard error of the mean (SEM).
RESULTS
Active Angiogenesis in Ovarian Grafts Depicted by
DCE MRI
Serial MR scans from as early as 7 days up to 60 days after
transplantation were performed to delineate the changes in
ovarian graft angiogenesis and vascular function (Akt1þ/þ,
n ¼ 5, 5, 6, 5; Akt1/, n ¼ 3, 3, 7, 7 for days 7, 14, 30,VOL. 101 NO. 2 / FEBRUARY 2014
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the macromolecular contrast agent biotin-BSA-GdDTPA
was still conﬁned to the intravascular space, outlining the
main branches of arteries and veins in the surrounding mus-
cle. Moreover, it also depicted the microvascular network in-
side the graft (Fig. 1A). Serially scanning the graft up to 40
minutes after injection of contrast agent, we recorded the
extravasation of biotin-BSA-GdDTPA from leaky graft blood
vessels (see Fig. 1B, C).
Dynamic imaging allowed us to calculate vascular pa-
rameters indicating vascular density (fBV) and permeability
(PS). As expected for a site with increased angiogenic
response, the fBV and PS values were higher in the graft
compared with the muscle surrounding it (Fig. 2A, B). Fluo-
rescence microscopy depicted a similar distribution of
macromolecular contrast material, showing a high intravas-
cular signal of BSA-ROX in ovarian grafts with high fBV
values (see Fig. 2C). Grafts with a high PS value showed a
high signal intensity of avidin–CY2-biotin-BSA-GdDTPA
conjugates, mainly in antral follicles, corpora lutea, and in
the stroma of the graft (see Fig. 2D–F). The muscle surround-
ing the grafts had very low fBV and PS in all animals and at
all time points.Reduced Angiogenesis in Akt1L/L Ovarian Grafts
The angiogenic response in the ovarian grafts was scored by
MR-derived mean fBV and PS values. Subsequently, we
searched for variations in the mean fBV and PS values
over time. Although the fBV was apparently higher in the
Akt1/ grafts 7 days after transplantation, it did not reach
statistical signiﬁcance (0.0426  0.014 vs. 0.0194  0.008,
P¼ .205; Akt1/, n ¼ 3; Akt1þ/þ, n ¼ 5). Furthermore, no
differences were found in the mean fBV at days 14 and 30.
Nevertheless, on day 60, the fBV was statistically signiﬁ-
cantly lower in the Akt1/ grafts (0.0126  0.002 vs.FIGURE 1
DCE MRI of Akt1þ/þ ovarian graft 60 days after transplantation in the bicep
3D images of ovarian graft: (A) Early vascular ﬁlling, at the ﬁrst time point
extravasation (permeability) and accumulation 40 minutes after the inject
point (B) in green. Scale bar: 5 mm. Shown are ovarian graft (arrow) an
lymph node.
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VOL. 101 NO. 2 / FEBRUARY 20140.0357  0.007, P< .05; Akt1/, n ¼ 7; Akt1þ/þ, n ¼ 5)
(Fig. 3A, B). On day 7, the contrast agent accumulated
with time in the ovarian graft. However, 60 days after trans-
plantation, the contrast agent was abnormally distributed in
the Akt1/ grafts, mainly at the rim, with minimal ﬁlling
of the graft vasculature (Supplemental Fig. 1, available
online). We further analyzed PS in the ovarian grafts; at
day 60 after transplantation, the mean PS was statistically
signiﬁcantly lower in the Akt1/ grafts compared with
the Akt1þ/þ grafts (0.0007  0.0002 vs. 0.0022  0.0005
min1, P< .05; Akt1/, n ¼ 7; AKt1þ/þ, n ¼ 5) (see
Fig. 3C, D).
The ovarian graft volume measured from the MRI data
showed a gradual increase over time in both Akt1/ mice
and controls. The mean graft volume was similar in Akt1/
mice and controls from 7 to 60 days after transplantation (see
Fig. 3E).Microscopic Analysis of Ovarian Grafts
The follicular reserve, graft structure, and transplantation site
were assessed in histologic sections stained with hematoxylin
and eosin (H&E) (Akt1þ/þ, n ¼ 6; Akt1/, n ¼ 7; 3–16 sec-
tions per graft, according to the size of the graft). Sixty days
after transplantation, 5 (83%) of 6 Akt1þ/þ ovarian grafts
contained follicles that developed up to the antral stage (see
Fig. 4C). The presence of corpora lutea in three grafts
conﬁrmed that some follicles had completed their develop-
ment and ovulated. On the other hand, in Akt1/ mice we
found high rates of graft destruction with complete loss of
follicular reserve and disruption of the normal ovarian tissue
architecture. In these Akt1/ grafts, only 1 (12.5%) of 7 con-
tained follicles that developed up to the antral stage, whereas
the rest showed signs of ovarian tissue destruction and com-
plete follicular loss. None of the Akt1/ grafts contained
corpora lutea (see Fig. 4D).s femoris muscle of the thigh, maximal intensity projections of selected
(3 minutes) after injection of biotin-BSA-GdDTPA. (B) Contrast agent
ion. (C) Overlay image of the ﬁrst time point (A) in red and last time
d accumulation of contrast in ovarian follicles (arrowhead). *Sciatic
539
FIGURE 2
Histologic validation of MRI-derived fBV and PS values. (A–B) Akt1þ/þ graft 60 days after transplantation showing high fBV and PS values. The fBV
and PS maps are overlaid on 3D maximal intensity projection image of the leg. (C) Fluorescence microscopy of functional blood vessels (BSA-ROX
injected 2 minutes before animals were killed; red). (D) Permeability assessed by the extravasation of contrast agent 40 minutes after injection of
biotin-BSA-GdDTPA (visualized with avidin-CY2-biotin-BSA-GdDTPA; green). (E) Overlay of C and D. (F) Higher magniﬁcation of the box in E. Scale
bar: 5 mm. Shown are ovarian graft (arrow) and muscle surrounding the graft (arrowhead).
Cohen. Ovarian graft reception depends on Akt1. Fertil Steril 2014.
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grafts is induced by ovarian grafting and is not merely the
result of spontaneous degeneration of the native ovary due
to Akt1 deﬁciency, we assessed the ovarian morphology of
adult cycling mice (Akt1þ/þ, n ¼ 2; Akt1/, n ¼ 5). Native
Akt1/ ovaries had a normal ovarian structure, with
normal-looking follicles at different stages of development,
from primordial follicles to corpora lutea (see Fig. 4A, B).
The Akt1þ/þ grafts developed a considerable vascular
network both at the outer rim of the graft (graft muscle inter-
face) and in the ovarian tissue. Moreover, this newly formed
vasculature expressed markers for blood vessel maturation,
as was evident from the presence of a-SMA–expressing cells
in the vessel wall. In contrast, the Akt1/ grafts were char-540acterized by a paucity of blood vessels in the grafts and in
the adjacent muscle, with reduced vascular maturation
(Supplemental Fig. 2, available online).DISCUSSION
Successful fertility preservation via ovarian graft trans-
plantation depends mainly on rapid reestablishment of vascu-
larization and perfusion to the graft. Decreasing
posttransplantation hypoxia will protect the primordial follicle
reserve and ensure the highest chance for retrievingmature oo-
cytes for in vitro fertilization (IVF). The results of this study
delineate the main role of Akt1 in ovarian graft reception,
but, surprisingly, despite the major role of Akt1 inVOL. 101 NO. 2 / FEBRUARY 2014
FIGURE 3
Variations in fBV, PS, and graft size over time. Mean (A) fBV and (C) PS values. RepresentativeMRI-derived (B) fBV and (D) PS maps of corresponding
time points. The fBV and PS values are shown for graft ROI overlaid on maximal intensity projections. The fBV and PS values increased over time in
Akt1þ/þ grafts and decreased in Akt1/ grafts and were signiﬁcantly lower 60 days after transplantation. (E) Gradual increase in graft size over
time. Themean graft volumewasmeasured byMRI. No differences in size were found between Akt1/ and Akt1þ/þ grafts. (Akt1þ/þ, n¼ 5, 5, 6, 5
mice; Akt1/, n ¼ 3, 3, 7, 7 mice for days 7, 14, 30, and 60, respectively). Scale bar: 5 mm. Data are presented as mean  SEM. *P<.05.
Cohen. Ovarian graft reception depends on Akt1. Fertil Steril 2014.
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not in the early stages of angiogenesis but in the long-term sur-
vival of the graft. Using MRI-based, in vivo imaging tech-
niques, we were able to observe ovarian grafts and document
a gradual decrease in the microvascular density and perme-
ability of blood vessels in Akt1/ grafts with time after trans-
plantation, ultimately leading to complete or near-complete
graft destruction coinciding with massive follicular loss.
A number of strategies to accelerate angiogenesis in
ovarian grafts have been investigated. Primarily, the trans-
plantation site should be able to support rapid revasculariza-
tion and maintain graft perfusion. Intramuscular and
intraperitoneal transplantations appear to provide better
vascular maintenance as compared with either subcutane-
ous or under-the-kidney bursa transplantations (25, 26).
Other methods to improve vascular support include
transplantation-site preconditioning by a surgical incision
that creates granulation tissue and recruitment of proangio-
genic factors and endothelial cells (10, 27). The
administration of VEGF at the transplantation site did not
improve extrapelvic autologous ovarian graft reception in
primates (28). However, it has been suggested that graft
incubation in hyaluronan, VEGF-A, and vitamin E before
transplantation can improve ovarian graft survival (11).VOL. 101 NO. 2 / FEBRUARY 2014Akt1 is a principal mediator in the PI3K-signaling
pathway, controlling a complex downstream signaling
network. Thus, its overall effect on angiogenesis under hyp-
oxic conditions is sometimes elusive and depends on the
time span of Akt1 activation and tissue-speciﬁc factors. It
has been reported that the loss of Akt1 increases angiogenesis
(20, 29). On the other hand, it also has been reported that loss
of Akt1 impairs postischemic VEGF-mediated angiogenesis
(18). To the best of our knowledge, our study is the ﬁrst report
on the role of Akt1 in ovarian grafting. We show that Akt1 ac-
tivity is required for long-term induced angiogenic conditions
that appear to be essential for ovarian graft reception. The ef-
fect of Akt1 loss in ovarian grafts is time dependent, suggest-
ing the contribution of different compensating mechanisms:
7 to 60 days after transplantation, MR data indicated a
gradual decrease in fBV and PS in Akt1/ ovarian grafts.
Impaired long-term angiogenesis in Akt1/ grafts is consis-
tent with Ackah et al. (18), who reported defective recovery in
blood ﬂow, severe tissue ischemia, and reduced capillary
density in Akt1/ mice and after femoral artery resection.
However, Akt1/ grafts survive the immediate posttrans-
plantation hypoxic period initially; on day 7, when ovarian
graft revascularization is expected, there were no signiﬁcant
differences in fBV and PS in Akt1/ compared with Akt1þ/þ.541
FIGURE 4
Loss of Akt1/ ovarian grafts. (A, B) Ovarian morphology of adult native Akt1þ/þ and Akt1/ ovaries (13 to 24 weeks old). Representative ovarian
mid section H&E staining of Akt1þ/þ (A) and Akt1/ (B) are shown. (C, D) H&E sections of ovarian grafts 60 days after transplantation showing
successful reception of Akt1þ/þ graft with follicular maturation up to the antral stage (C) and Akt1/ graft destruction (D). Severe morphologic
changes in Akt1/ grafts induced by grafting were not found in the native ovary. Arrows: antral follicles.
Cohen. Ovarian graft reception depends on Akt1. Fertil Steril 2014.
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in Akt1/ mice that was reported by Chen et al. (20). Never-
theless, this study did not test the direct affect of hypoxia on
tissues with loss of Akt1.
Angiogenesis is critical for follicle growth and ovarian
function. Developing follicles depend on the formation of
a capillary network and increased vascular density at the
preantral stage (30), and the correlation between vascular
development and follicle reserve is well documented (31).
Inhibition of angiogenesis will have a detrimental effect
on follicular growth (32). In the human ovary, more than
6 months are required for a primary follicle to reach the
antral stage and respond to recruitment by follicle-
stimulating hormone. In rats, more than 2 months are
required for this process (33). Therefore, successful ovarian
grafting depends not only on rapid posttransplantation re-
perfusion and preservation of ovarian reserve but also on
long-term, dynamic, adequate angiogenic support. Angio-
genesis is a composite dynamic process that starts with
endothelial-cell recruitment by angiogenic stimuli, followed
by tip-cell protrusion, stalk-cell support, lumen formation,
and vascular network branching. Mural cells such as peri-
cytes, and smooth muscle cells are recruited to complete
the ﬁnal stage of vascular maturation (34). We used
a-SMA as a marker for blood vessel maturation. At the
end point of the study, the Akt1/ ovarian grafts showed
reduced expression of a-SMA in their vasculature, accom-
panied by mean fBV and PS values that were about three
times higher than in Akt1þ/þ.
In our model, we assessed MRI-derived angiogenic pa-
rameters fBV and PS as biomarkers for graft viability. Evalu-
ating fBV and PS enabled us to quantify changes in blood542vessel density and function. The reduced long-term angio-
genesis that was recorded in Akt1/ grafts may arise from
one of the following alternatives or from a combination of
them. [1] Impaired angiogenesis antecedent ovarian follicle
loss may possibly, with time after grafting, have an impact.
The growing pool of maturing follicles in Akt1/ grafts
increased the demand on ovarian perfusion up to a level
that could not be supported by the primary vascular network
that was formed 7 days after transplantation, ultimately lead-
ing to signiﬁcantly reduced follicular reserve and graft
destruction 60 days later. [2] Changes in vascular density
and permeability that are secondary to reduction in follicle
numbers may be reﬂected. Tissue adaptation after grafting
depends on many cellular mechanisms such as proliferation,
growth, and inﬂammation that may be altered in Akt1/
grafts (35). Variation in fBV can result from differences in
the number of developing follicles. Histologic sections at
different points in time are not available in our model, yet it
should have inﬂuenced the volume of the graft. Both
Akt1/ and Akt1þ/þ grafts increased in size over time, and
no statistically signiﬁcant differences were found. On day
60, an unusual distribution of the contrast agent was depicted
in Akt1/ grafts. Instead of ﬁlling the graft vasculature, it
accumulated at the rim. This abnormal vascular changes
and reduced graft perfusion with no change in graft size sup-
port a primary angiogenic deﬁciency in Akt1/ grafts.
Nevertheless, the cause and effect of this observation has
yet to be established. Regardless of underlying mechanism
in ovarian graft loss, our model delineates the role of Akt1
in ovarian graft reception.
Although tissue hypoxia is the main challenge in ovarian
graft reception, Akt1 loss in our transgenic model might haveVOL. 101 NO. 2 / FEBRUARY 2014
Fertility and Sterility®a cellular effect beyond angiogenesis. The PI3K-Akt pathway
has a vital role in primordial follicle activation and ovarian
reserve maintenance (36, 37). Although Akt1/ female
mice exhibit subfertility, it is still possible to breed them,
and they deliver pups. We compared the native ovary and
ovarian grafts from Akt1/ mice to verify that reduced
angiogenic response and severe morphologic changes in
Akt1/ grafts are induced by grafting and are not intrinsic
to the native ovary. Furthermore, it has been reported that
at postnatal day (PND) 25 Akt1/ and Akt1þ/þ contain a
similar number of primordial and primary follicles. In our
study, the Akt1/ grafts were retrieved at PND 35–42, thus
signiﬁcantly reduced ovarian reserve at time of
transplantation was not expected. At PND 90, which
corresponds with the age of ovarian grafts 60 days after
transplantation, Brown et al. (38) found no difference in the
number of antral follicles or comparable levels of estradiol
and progesterone in Akt1/ and Akt1þ/þ ovaries. On the
other hand, activation of the PI3K-signaling pathway acti-
vates dormant primordial follicles (36). Oocyte PTEN deletion
leads to Akt activation and subsequent activation of the entire
primordial follicle and premature ovarian failure in early
adulthood (37). Based on these studies and our results, signif-
icantly reduced follicular reserve or premature depletion of
primordial follicles in Akt1/ native ovaries (‘‘burn-out’’),
which could have biased the results of ovarian graft trans-
plantation, can be ruled out. Akt1/ ovarian grafts destruc-
tion on day 60 does not correlate with the reproductive
potential of Akt1/ female mice or the morphologic changes
in the native Akt1/ ovary (38). Akt1/ ovarian graft loss is
the result of pathologic graft reception.
Our data, based on long-term serial MRI follow-up obser-
vations to quantify angiogenic responses during the critical
hypoxic posttransplantation period, delineate the critical
role of Akt1 in ovarian graft reception. Although ovarian
grafts lacking Akt1 activity appear to survive the immediate
posttransplantation period, long-term graft survival is
impaired, ultimately leading to graft destruction.
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SUPPLEMENTAL FIGURE 1
Reduced perfusion in Akt1/ 60 days after transplantation. 3D MRI of ovarian grafts 7 and 60 days after transplantation, and 40 minutes after
injection of biotin-BSA-GdDTPA. (A, B) Abnormal distribution of the contrast agent at the rim and reduced perfusion on day 60 in Akt1/
grafts compared with day 7. (C, D) Normal vascular ﬁlling in controls. Arrow: ovarian graft.
Cohen. Ovarian graft reception depends on Akt1. Fertil Steril 2014.
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SUPPLEMENTAL FIGURE 2
Reduced pericytes recruitment and vascular maturation in Akt1/ grafts. a-SMA immunostaining of Akt1þ/þ graft: (A–D) Different magniﬁcations
and regions of the same graft, disclosing numerousmature blood vessels inside the graft (C) and in the adjacent muscle (D). (E, F) Akt1/ graft with
paucity of mature blood vessels both inside the graft and at the rim of transplantation site. Arrows: Blood vessels stained with a-SMA. *Ovarian
graft.
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